IMMUNOFORGE
- Biotech or pharma, therapeutic R&D
Clinical-stage company with ELP platform to enable weekly injection of peptide-based drugs. Targeting inflammatory muscle conditions polymyositis/dermatomyositis, DMD, also DMD cardiomyopathy, achondroplasia, short bowel syndrome, drug-resistant CML (NCE)
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}